Meeting
Abstract Number: 41
SHM Converge 2023
Background: Alcohol use disorder (AUD) is the most prevalent substance use disorder, but most patients with AUD do not receive evidence-based medications for AUD (MAUD), including naltrexone or acamprosate. Inpatient addiction consult services (ACS) may offer an opportunity to start medical treatment for hospitalized patients with AUD, but it is unknown if ACS are associated […]
Abstract Number: 60
SHM Converge 2023
Background: Unlike other chronic conditions such as diabetes mellitus and heart disease, substance use disorder (SUD) has only recently been recognized by the medical community recently as a medical condition, and stigmatizing beliefs have lingered. Formal teaching about SUD has been shown to foster a more positive attitude towards these patients among medical trainees. Attitudes […]
Abstract Number: 812
SHM Converge 2023
Case Presentation: A 34-year-old male with a history of opioid use disorder (OUD) was admitted after being found down secondary to heroin overdose. He was given 4 mg naloxone in the field with improvement in Glasgow Coma Score from 3 to 12. After naloxone administration, he was tachycardic, tachypneic, hypertensive, and agitated. He reported taking […]
Abstract Number: 848
SHM Converge 2023
Case Presentation: A 43-year-old woman with general anxiety disorder and benzodiazepine abuse was brought to the emergency department by her husband with nausea, diarrhea, agitation, and altered mental status. She also endorsed restlessness and muscle tension. Examination revealed an agitated, disoriented woman with three days of amnesia. Vitals signs were within normal limits. Drug and […]